Cancer patient service fears
THE new boss of Tasmania’s peak cancer advocacy group has raised fears a discussion paper looking at the future regulation of community transport threatens the lifesaving Transport2Treatment (T2T) bus service.
Read more on The Advocate
Dendreon Rises After Winning Approval for Cancer Drug (Update2)
April 29 (Bloomberg) — Dendreon Corp. won approval for its first product, a vaccine to fight prostate cancer, after a three-year battle with U.S. regulators. Shares surged the most in a year in New York trading.
Read more on Bloomberg
Calling all councils: Ex-town clerk’s cancer plea
VERN Robson has long been a campaigner for cancer services in the south-west.
Read more on Warrnambool Standard